What Happened
The University at Buffalo is reporting continued momentum in translating faculty research into startup companies through its Business and Entrepreneur Partnerships (BEP) organization. Serving as the university’s central commercialization office, BEP has expanded its role beyond traditional technology transfer by engaging researchers much earlier in the commercialization process and helping them evaluate startup formation alongside conventional licensing strategies.
BEP connects faculty founders with commercialization planning, intellectual property management, customer discovery through NSF I-Corps, experienced business leaders, incubator space at Baird Research Park and the Center of Excellence in Bioinformatics and Life Sciences, and multiple sources of proof of concept and translational funding. Programs including the Buffalo Innovation Accelerator Fund (BIAF), UB CAT, the Center of Excellence in Materials Informatics (CMI), and New York State commercialization initiatives provide early-stage support that frequently positions companies for larger federal awards.
The strength of the model is reflected across a diverse portfolio of faculty-founded companies. AI and digital health ventures such as QAS.AI, Auspex Medix, and Empath Medical Innovations have secured NIH, NSF, and industry funding. Therapeutics companies including POP Biotechnologies and Neurovascular Diagnostics continue attracting significant federal investment, while companies such as Aerammonia, IBEX Materials, and TouchTronix Robotics demonstrate commercialization opportunities in advanced manufacturing, energy, robotics, and materials science.
What This Means for GAP Leaders
University at Buffalo’s approach highlights several characteristics of a mature commercialization ecosystem.
- Commercialization begins before company formation. Faculty receive commercialization planning, customer discovery, and funding strategy support well before incorporation.
- Multiple proof of concept funding mechanisms reduce technical risk. University, state, and federal programs create a staged capital pathway that prepares ventures for larger follow-on awards.
- Integrated support strengthens commercialization outcomes. Technology transfer, incubators, entrepreneurial expertise, and translational funding function as complementary components rather than isolated programs.
- Sector diversity creates resilience. The commercialization pipeline supports ventures across life sciences, AI, digital health, advanced materials, robotics, and energy technologies.
Strategic System Insight
The University at Buffalo demonstrates how commercialization offices are evolving from transactional technology transfer organizations into comprehensive venture development platforms.
Rather than measuring success primarily through licensing activity, BEP actively helps researchers evaluate commercialization pathways, connect with experienced entrepreneurs, secure proof of concept funding, enter incubators, and prepare for federal grants and private investment. This coordinated model allows commercialization decisions to occur earlier, when team formation, customer discovery, intellectual property strategy, and funding decisions have the greatest influence on long-term success.
The repeated progression from university translational funding to NIH, NSF, SBIR/STTR, NYSTAR, and private investment illustrates how staged commercialization support can amplify the impact of institutional resources. Rather than replacing external funding, BEP’s programs position startups to compete successfully for larger sources of capital while reducing technical and commercial risk along the way.
For GAP leaders, the broader lesson is that sustainable startup formation depends less on any individual fund or accelerator than on the integration of technology transfer, proof of concept funding, incubators, commercialization expertise, and strategic partnerships into a coordinated innovation ecosystem.
Source Story: University at Buffalo UBNow
https://www.buffalo.edu/ubnow/stories/2026/08/bep-research-to-startup.html
Related Topics:
gap fund and accelerator programs (GAP), technology commercialization, translational research, university venture fund, proof of concept funding, technology transfer, incubators, SBIR/STTR, startup accelerator, AI, digital health, advanced manufacturing, capital formation, university innovation
Explore More
Mind the GAP Report: The Most Comprehensive Guide to University GAP Funding Programs
